Vimarsana
Biggest News Aggregation in the World

Asterra Labs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Asterra Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Asterra Labs Today - Breaking & Trending Today

Asheville, Buncombe Become 'Epicenters' of Hemp, the Accidental Industry Bigger Than Marijuana - Vimarsana News

Asheville, Buncombe Become 'Epicenters' of Hemp, the Accidental Industry Bigger Than Marijuana

Proliferation of intoxicating products leads to calls for more regulation to protect consumers

The budding NC market for safe, consistent hemp products - Vimarsana News

The budding NC market for safe, consistent hemp products

There is a new and thriving market for hemp products in North Carolina and across the country; you've probably noticed the convenient store shelves full of CBD gummies, smokable hemp flower, vape pens, and more. But who's making them, and by what standards, is often an open question in this new free-for-all economy. The nascent

The budding NC market for safe, consistent hemp products - Vimarsana News

The budding NC market for safe, consistent hemp products

There is a new and thriving market for hemp products in North Carolina and across the country; you’ve probably noticed the convenient store shelves full of CBD gummies, smokable hemp

Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 121: Kevin Sills, CEO, Asterra Labs | Nexsen Pruet, PLLC - Vimarsana News

Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 121: Kevin Sills, CEO, Asterra Labs | Nexsen Pruet, PLLC

Heather and Matthew welcome Kevin Sills of Asterra Labs, which develops and manufactures pharmaceutical grade, quality cannabinoid products. As a leader in the industry, Kevin offers...

Related Topics:
Kevin SillsAsterra Labs
Validcare Announces a Second Cohort of CBD Brands Joins Safety Study to Gather Data for FDA - Vimarsana News

Validcare Announces a Second Cohort of CBD Brands Joins Safety Study to Gather Data for FDA

Validcare Announces a Second Cohort of CBD Brands Joins Safety Study to Gather Data for FDA Share Article Validcare's Decentralized Clinical Trial Allows for Consumer Participation During COVID "We are excited to have our state of the art, decentralized trial technology overcome the hurdles of performing research during a pandemic." DENVER (PRWEB) April 15, 2021 Validcare announced today the addition of a second cohort of CBD brands participating in a large scale, human safety study, a significant and widescale endeavor to answe...

Source: prweb.com